Polymorphisms of ADIPOQ are linked with metabolic syndromes: for example, insulin resistance, abdominal obesity, impaired glucose tolerance, dyslipidemia, hypertension, increased fasting glucose [9, 10], and plasma adiponectin level [11, 12]. This evidence concerns the gene ADIPOQ and Abdominal obesity.